The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Caffeine, Mental Health, and Psychiatric Disorders
Open accessAbstract
Caffeine intake is so common that its pharmacological effects on the mind are undervalued. Since it is so readily available, individuals can adjust their own dose, time of administration and dose intervals of caffeine, according to the perceived benefits and side effects of each dose. This review focuses on human studies of caffeine in subjects with and without psychiatric disorders. Besides the possibility of mild drug dependence, caffeine may bring benefits that contribute to its widespread use. These benefits seem to be related to adaptation of mental energy to the context by increasing alertness, attention, and cognitive function (more evident in longer or more difficult tasks or situations of low arousal) and by elevating mood. Accordingly, moderate caffeine intake (< 6 cups/day) has been associated with less depressive symptoms, fewer cognitive failures, and lower risk of suicide. However, its putative therapeutic effects on depression and ADHD have been insufficiently studied. Conversely, in rare cases high doses of caffeine can induce psychotic and manic symptoms, and more commonly, anxiety. Patients with panic disorder and performance social anxiety disorder seem to be particularly sensitive to the anxiogenic effects of caffeine, whereas preliminary data suggests that it may be effective for some patients with obsessive compulsive disorder (OCD). The threshold for the anxiogenic effect of caffeine is influenced by a polymorphism of the A2A receptor. In summary, caffeine can be regarded as a pharmacological tool to increase energy and effortful behavior in daily activities. More populational (cross-sectional and prospective) and experimental studies are necessary to establish the role of caffeine intake in psychiatric disorders, especially its putative efficacy on depressive mood and cognitive/attentional disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 2×
“In contrast, higher dopamine activity leads to increased salience perception, which probably contributes to bipolar mania [125] and may be the final common pathway for psychosis [126].”
BackgroundFredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 2×
“dopamine, glutamate, and acetylcholine [4,5].”
BackgroundEvaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728 · cited 10×
“Interestingly, caffeine improves cognitive performance in an animal model of ADHD [121] and promotes effortrelated behavior in animals treated with dopamine antagonists [122].”
BackgroundInfluentialAn Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440 · cited 2×
“dopamine, glutamate, and acetylcholine [4,5].”
The interactive effect of personality, time of day, and caffeine: A test of the arousal model.
Revelle, W., Humphreys, M. S., Simon, L., & Gilliland, K. (1980) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.109.1.1 · Cited by 422
The effects of low doses of caffeine on human performance and mood
Lieberman, H. R., Wurtman, R. J., Emde, G. G., Roberts, C., & Coviella, I. L. G. (1987) · Psychopharmacology · doi:10.1007/bf00210835 · Cited by 413
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Withdrawal Syndrome after the Double-Blind Cessation of Caffeine Consumption
Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271601 · Cited by 380 · cited 1×
“Caffeine cessation over a couple of days may increase anxiety and depression scores in about 10% of volunteers with a moderate daily intake (mean 235 mg per day), and lead to headache in about 50% of volunteers [55].”
BackgroundHaskell, C. F., Kennedy, D. O., Wesnes, K. A., & Scholey, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2104-3 · Cited by 356
Smit, H. J., & Rogers, P. J. (2000) · Psychopharmacology · doi:10.1007/s002130000506 · Cited by 339
Cited by
van Dam, R. M., Hu, F. B., & Willett, W. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1816604 · Cited by 508
Prevalence of psychological stress, depression and anxiety among medical students in Egypt
Fawzy, M., & Hamed, S. A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.05.027 · Cited by 455
Lifestyle medicine for depression
Sarris, J., O’Neil, A., Coulson, C. E., Schweitzer, I., & Berk, M. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-107 · Cited by 450
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children
Richards, G., & Smith, A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115612404 · Cited by 179
Sweetened beverages, coffee, and tea and depression risk among older US adults
Guo, X., Park, Y., Freedman, N. D., Sinha, R., Hollenbeck, A. R., Blair, A., & Chen, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094715 · Cited by 161
Caffeine Induces Neurobehavioral Effects through Modulating Neurotransmitters
Alasmari, F. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.02.005 · Cited by 113
“Importantly, studies showed that moderate consumption of caffeine (less than 6cups/day) exhibited ability to attenuate cognitive failure, suicide and symptoms of major depressive disorder while high doses of caffeine may lead to psychosis and anxiety (Lara, 2010).”
Cook, C. J., Crewther, B. T., Kilduff, L. P., Drawer, S., & Gaviglio, C. M. (2011) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-8-2 · Cited by 104
“Effective doses of caffeine (and their dose response nature) remain contentious in literature [1,5,6,27] possibly reflecting larger inter-subject variability in responses and different sensitivities of various physical and behavioural expressions.”
Al Bahhawi, T., Albasheer, O. B., Makeen, A. M., Arishi, A., Hakami, O., Maashi, S., Al-Khairat, H. K., Alganmy, O., Sahal, Y., Sharif, A., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s182744 · Cited by 94
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033243 · Cited by 87
“…high caffeine intake that are virtually indistinguishable from severe chronic anxiety; however, caffeinism appears to be a specific condition, and there is little evidence for correlations between caffeine intake and anxiety in either nonclinical volunteers or psychiatric outpatients (Lara 2010).”
BackgroundMcMahon, G., Taylor, A. E., Davey Smith, G., & Munafò, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103448 · Cited by 49
Park, G. H., Song, H. M., & Jeong, J. B. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.07.008 · Cited by 35
Rizkallah, É., Bélanger, M., Stavro, K., Dussault, M., Pampoulova, T., Chiasson, J., & Potvin, S. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00951.x · Cited by 27
Silva, H., Del Coso, J., & Pickering, C. (2025) · Sports Medicine · doi:10.1007/s40279-025-02245-y · Cited by 21
Naftalovich, H., Tauber, N., & Kalanthroff, E. (2020) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2020.102316 · Cited by 14
Comorbidity between Substance Use Disorder and Severe Mental Illness
Adan, A., & Benaiges, I. (2016) · Neuropathology of Drug Addictions and Substance Misuse · doi:10.1016/b978-0-12-800634-4.00026-3 · Cited by 5
Metadata
- Authors
- Lara, D. R.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-04-14
- Volume
- 20
- Issue
- s1
- Pages
- S239-S248
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1563640261
- Cited by
- 233
- References
- 28
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.